Growth in the oncology drug market continues to spur demand for high-potency API manufacturing. Which CDMOs/CMOs are expanding? DCAT Value Chain Insights rounds up the latest investments.

Key topics: (see Chapter Markers in drop down menu in audio player above)

• A roundup of recent investments in HPAPI manufacturing (1:14)
• WuXi STA (1:31)
• MilliporeSigma (2:28)
• Piramal Pharma Solutions (3:25)
• Cambrex (5:26)
• HAS Healthcare Advanced Synthesis (7:07)
• AGC Fine Chemicals (8:30)
• Lonza (9:11)
• Carbogen Amcis (11:44)
• Sterling Pharma Solutions (12:14)
• Ajinomoto Bio-Pharma Services (13:22)
• Novasep (14:02)
• Olon (14:47)
• Cerbios-Pharma (16:36)
• Formosa Laboratories (17:44)
• Sai Life Sciences (18:31)
• BSP Pharmaceuticals (19:15)
• Seqens (20:01)
• CordenPharma (20:14)

Sponsor: BIOVECTRA

Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show